FIELD: analytical; pharmaceutical chemistry.
SUBSTANCE: invention relates to a method for the quantitative determination of dexamethasone in biological media. A method for the quantitative determination of dexamethasone in biological media using HPLC with ultraviolet detection is proposed, according to which the extraction of dexamethasone from biosamples is carried out by liquid-liquid extraction with acetone in an acidic medium, a mixture of methanol and phosphate buffer in a ratio of 50:50 is used as the mobile phase, the stationary phase represented by Kromasil 100 С18, 250 column×4.6 mm, 5 µm, detection is carried out at 241 nm, and atenolol is used as an internal standard.
EFFECT: above method is a highly sensitive for the determination of dexamethasone in biological media using HPLC-UV.
1 cl, 7 dwg, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR DETERMINING AMIODARONE AND ITS MAIN METABOLITE DESETHYLAMIODARONE IN HUMAN BLOOD SERUM | 2020 |
|
RU2749566C1 |
METHOD OF QUANTITATIVE DETERMINATION OF ANTIHYPERTENSIVE AGENTS IN BLOOD PLASMA | 2022 |
|
RU2803887C1 |
METHOD FOR DETERMINING THE DRUG METFORMIN IN MIXED SALIVA OF A PATIENT SUFFERING DIABETES MELLITUS | 2019 |
|
RU2705363C1 |
METHOD FOR DETERMINING LOSARTAN, ITS MAIN METABOLITE LOSARTAN CARBOXYLIC ACID AND GLIBENCLAMIDE IN HUMAN BLOOD SERUM AND URINE | 2020 |
|
RU2749567C1 |
METHOD FOR DETERMINING DABIGATRAN IN HUMAN BLOOD SERUM | 2018 |
|
RU2683032C1 |
METHOD FOR THE QUANTITATIVE DETERMINATION OF 2-ISOPROPYL-5-METHYLCYCLOHEXYL 2-(1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETATE AND INDOMETHACIN IN BLOOD PLASMA | 2021 |
|
RU2781342C1 |
METHOD OF QUANTIFICATION OF LEVODOPA IN BLOOD PLASMA | 2017 |
|
RU2665164C1 |
METHOD FOR QUANTITATIVE DETERMINATION OF LYCARBAZEPINE IN BLOOD PLASMA | 2017 |
|
RU2660364C1 |
METHOD FOR MEASURING THE CONCENTRATION OF POLYGLUTAMATES OF METHOTREXATE BY HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY WITH MASS SPECTROMETRIC DETECTION (HPLC-MS/MS) | 2020 |
|
RU2752805C1 |
METHOD FOR THE QUANTITATIVE DETERMINATION OF ANTICONVULSANTS IN THE BLOOD PLASMA OF PATIENTS WITH EPILEPSY | 2021 |
|
RU2771430C1 |
Authors
Dates
2023-03-21—Published
2022-12-23—Filed